TY - JOUR AU - Hou, Min AU - Xing, Haiyan AU - Cai, Yongqing AU - Li, Bin AU - Wang, Xianfeng AU - Li, Pan AU - Hu, Xiaolin AU - Chen, Jianhong PY - 2017 DA - 2017/04/07 TI - The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis JO - The Journal of Headache and Pain SP - 42 VL - 18 IS - 1 AB - Migraine has been recognized as one of the leading causes of disability in the 2013 Global Burden of Disease Study and seriously affects the quality of patients’ life, current treatment options are not ideal. Monoclonal antibodies to calcitonin gene-related peptide and its receptor (CGRP-mAbs) appear more promising for migraine because of considerably better effect and safety profiles. The objective of this study is to systematically assess the clinical efficacy and safety of CGRP-mAbs for migraine therapy. SN - 1129-2377 UR - https://doi.org/10.1186/s10194-017-0750-1 DO - 10.1186/s10194-017-0750-1 ID - Hou2017 ER -